Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-04-22 | New | $6,600,000 | $6,600,000 | Equity Only | 06b | SEC link |
| 2020-05-29 | Amended | $145,204,965 | $51,999,979 | Equity Only | 06b | SEC link |
| 2020-04-13 | New | $93,204,986 | $93,204,986 | Equity Only | 06b | SEC link |
| 2018-05-07 | New | $5,999,999 | $5,999,999 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Helen M. Boudreau | Director |
| Wendy K. Chung | Director |
| Jeffrey Fryer | Executive |
| Robert Hopfner | Director |
| Rob Hopfner | Director |
| Ron Hunt | Director |
| Ronald M. Hunt | Director |
| Lucian Iancovici | Director |
| Jonathan I. Lieber | Executive |
| Hui Liu | Director |
| Martin W. Mackay | Director |
| Christine A. Nash | Director |
| Kush M. Parmar | Director |
| Ketan Patel | Director |
| Tim Shannon | Director |
| Paula Soteropoulos | Director |
| Stephen Uden | Director, Executive |